The epithelial to mesenchymal transition in pancreatic cancer: A systematic review

Pancreatology

Volumn 15, Issue 3, 2015, Pages 217-225

  Beuran, Mircea ^a,b   Negoi, Ionut ^a,b   Paun, Sorin ^a,b   Ion, Adriana Daniela ^b   Bleotu, Coralia ^c   Negoi, Ruxandra Irina ^b   Hostiuc, Sorin ^b,d  

^a Clinic Emergency Hospital Bucharest   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

^d NATIONAL INSTITUTE OF LEGAL MEDICINE MINA MINOVICI   (Romania)

Author keywords

Cancer stem cells; Emerging therapies; Epithelial to mesenchymal transition; Mesenchymal to epithelial transition; Molecular signals; Pancreatic cancer

Indexed keywords

FIBRONECTIN; UVOMORULIN; VIMENTIN; TUMOR MARKER;

BASEMENT MEMBRANE; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL SURVIVAL; DRUG RESISTANCE; EARLY CANCER; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; NONHUMAN; PANCREAS CANCER; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; CELL TRANSFORMATION; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR INVASION;

BIOMARKERS, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS;

EID: 84930178541     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2015.02.011     Document Type: Review

References (98)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 5 2010 277 300
2. D. Li, K. Xie, R. Wolff, and J.L. Abbruzzese Pancreatic cancer Lancet 363 9414 2004 1049 1057
3. H. Beger, and D. Birk Pancreatic cancer staging systems and their clinical impact H. Beger, A. Warshaw, M. Buchler, R. Kozarek, M. Lerch, J. Neoptolemos, The pancreas: an integrated textbook of basic science, medicine, and Surgery 2nd ed. 2008 Blackwell Publishing Limited 678 681
4. D. Shook, and R. Keller Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development Mech Dev 120 11 2003 1351 1383
5. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J Clin Invest 119 6 2009 1420 1428
6. R. Kalluri, and E. Neilson Epithelial-mesenchymal transition and its implications for fibrosis J Clin Invest 112 12 2003 1776 1784
7. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 6 2002 442 454
8. R. Kalluri EMT: when epithelial cells decide to become mesenchymal-like cells J Clin Invest 119 6 2009 1417 1419
9. J. Yang, and R.A. Weinberg Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Dev Cell 14 6 2008 818 829
10. B. Baum, J. Settleman, and M.P. Quinlan Transitions between epithelial and mesenchymal states in development and disease Semin Cell Dev Biol 19 3 2008 294 308
11. T. Brabletz To differentiate or not - routes towards metastasis Nat Rev Cancer 12 6 2012 425 436
12. B.P. Zhou, and M.C. Hung Wnt, hedgehog and snail: sister pathways that control by GSK-3beta and beta-Trcp in the regulation of metastasis Cell Cycle 4 6 2005 772 776
13. J.K. Sicklick Correcting the misnomers of epithelial-mesenchymal relations J Surg Res 182 1 2013 36 39
14. T. Große-Steffen-Steffen, T. Giese, N. Giese, T. Longerich, P. Schirmacher, and G.M. Hänsch epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase Clin Dev Immunol 2012 2012 12
15. G. Moreno-Bueno, F. Portillo, and A. Cano Transcriptional regulation of cell polarity in EMT and cancer Oncogene 27 55 2008 6958 6969
16. A.C. Martin, M. Kaschube, and E.F. Wieschaus Pulsed contractions of an actin-myosin network drive apical constriction Nature 457 7228 2009 495 499
17. M. Guarino Epithelial-mesenchymal transition and tumour invasion Int J Biochem Cell Biol 39 12 2007 2153 2160
18. A. Natalwala, R. Spychal, and C. Tselepis Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract World J Gastroenterol 14 24 2008 3792 3797
19. S. Nakajima, R. Doi, E. Toyoda, S. Tsuji, M. Wada, and M. Koizumi N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma Clin Cancer Res Official J Am Assoc Cancer Res 10 12 Pt 1 2004 4125 4133
20. N. Gavert, and A. Ben-Ze'ev beta-Catenin signaling in biological control and cancer J Cell Biochem 102 4 2007 820 828
21. T. Brabletz, A. Jung, S. Reu, M. Porzner, F. Hlubek, and L.A. Kunz-Schughart Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment Proc Natl Acad Sci USA 98 18 2001 10356 10361
22. T. Brabletz, A. Jung, K. Hermann, K. Gunther, W. Hohenberger, and T. Kirchner Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front Pathol Res Pract 194 10 1998 701 704
23. E. Karamitopoulou, I. Zlobec, D. Born, A. Kondi-Pafiti, P. Lykoudis, and A. Mellou Tumour budding is a strong and independent prognostic factor in pancreatic cancer Eur J Cancer 49 5 2013 1032 1039
24. N. Peparini Digestive cancer surgery in the era of sentinel node and epithelial-mesenchymal transition World J Gastroenterol 19 47 2013 8996 9002
25. I. Zlobec, and A. Lugli Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget Oncotarget 1 7 2010 651 661
26. M. Zeisberg, and E.G. Neilson Biomarkers for epithelial-mesenchymal transitions J Clin Invest 119 6 2009 1429 1437
27. U. Burk, J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan, and S. Spaderna A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep 9 6 2008 582 589
28. M.A. Huber, N. Kraut, and H. Beug Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr Opin Cell Biol 17 5 2005 548 558
29. J.M. Yingling, K.L. Blanchard, and J.S. Sawyer Development of TGF-beta signalling inhibitors for cancer therapy Nat Rev Drug Discov 3 12 2004 1011 1022
30. V. Ellenrieder, S.F. Hendler, W. Boeck, T. Seufferlein, A. Menke, and C. Ruhland Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation Cancer Res 61 10 2001 4222 4228
31. M.M. Javle, J.F. Gibbs, K.K. Iwata, Y. Pak, P. Rutledge, and J. Yu Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer Ann Surg Oncol 14 12 2007 3527 3533
32. S. Hindriksen, and M.F. Bijlsma Cancer stem cells, EMT, and developmental pathway activation in pancreatic tumors Cancers 4 4 2012 989 1035
33. I.B. Weinstein, and A. Joe Oncogene addiction Cancer Res 68 9 2008 3077 3080 [discussion 80]
34. I. Vivanco Targeting molecular addictions in cancer Br J cancer 111 11 2014 2033 2038
35. J. Son, C.A. Lyssiotis, H. Ying, X. Wang, S. Hua, and M. Ligorio Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway Nature 496 7443 2013 101 105
36. A. Kapoor, W. Yao, H. Ying, S. Hua, A. Liewen, and Q. Wang Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer Cell 158 1 2014 185 197
37. A. Singh, P. Greninger, D. Rhodes, L. Koopman, S. Violette, and N. Bardeesy A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival Cancer Cell 15 6 2009 489 500
38. X.Q. Wang, H. Li, V. Van Putten, R.A. Winn, L.E. Heasley, and R.A. Nemenoff Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9 Mol Biol cell 20 3 2009 791 800
39. S. Rachagani, S. Senapati, S. Chakraborty, M.P. Ponnusamy, S. Kumar, and L.M. Smith Activated KrasG(1)(2)D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin Br J Cancer 104 6 2011 1038 1048
40. J.P. Thiery Epithelial-mesenchymal transitions in development and pathologies Curr Opin Cell Biol 15 6 2003 740 746
41. I. Espinoza, R. Pochampally, F. Xing, K. Watabe, and L. Miele Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition Onco Targets Ther 6 2013 1249 1259
42. G. Feldmann, S. Dhara, V. Fendrich, D. Bedja, R. Beaty, and M. Mullendore Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers Cancer Res 67 5 2007 2187 2196
43. K.P. Olive, M.A. Jacobetz, C.J. Davidson, A. Gopinathan, D. McIntyre, and D. Honess Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer Science 324 5933 2009 1457 1461
44. J.M. Bailey, A.M. Mohr, and M.A. Hollingsworth Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer Oncogene 28 40 2009 3513 3525
45. K. Kim, Z. Lu, and E.D. Hay Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT Cell Biol Int 26 5 2002 463 476
46. Y. Takao, T. Yokota, and H. Koide Beta-catenin up-regulates Nanog expression through interaction with Oct-3/4 in embryonic stem cells Biochem Biophys Res Commun 353 3 2007 699 705
47. A. Apelqvist, H. Li, L. Sommer, P. Beatus, D.J. Anderson, and T. Honjo Notch signalling controls pancreatic cell differentiation Nature 400 6747 1999 877 881
48. B. Bao, Z. Wang, S. Ali, D. Kong, Y. Li, and A. Ahmad Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells Cancer Lett 307 1 2011 26 36
49. P. Hayward, K. Brennan, P. Sanders, T. Balayo, R. DasGupta, and N. Perrimon Notch modulates Wnt signalling by associating with Armadillo/beta-catenin and regulating its transcriptional activity Development 132 8 2005 1819 1830
50. Y. Tomizawa, T.T. Wu, and K.K. Wang Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus Oncol Lett 3 5 2012 1059 1063
51. G. Christofori New signals from the invasive front Nature 441 7092 2006 444 450
52. B. Hotz, M. Arndt, S. Dullat, S. Bhargava, H.J. Buhr, and H.G. Hotz Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer Clin cancer Res Official J Am Assoc Cancer Res 13 16 2007 4769 4776
53. S. Vega, A.V. Morales, O.H. Ocana, F. Valdes, I. Fabregat, and M.A. Nieto Snail blocks the cell cycle and confers resistance to cell death Genes Dev 18 10 2004 1131 1143
54. A. Aghdassi, M. Sendler, A. Guenther, J. Mayerle, C.O. Behn, and C.D. Heidecke Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer Gut 61 3 2012 439 448
55. G. Schneider, O.H. Kramer, and D. Saur A ZEB1-HDAC pathway enters the epithelial to mesenchymal transition world in pancreatic cancer Gut 61 3 2012 329 330
56. J. Yang, S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, and C. Come Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 7 2004 927 939
57. K. Ohuchida, K. Mizumoto, S. Ohhashi, H. Yamaguchi, H. Konomi, and E. Nagai Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of twist expression in pancreatic juice Int J Cancer 120 8 2007 1634 1640
58. J.M. Cates, R.H. Byrd, L.E. Fohn, A.D. Tatsas, M.K. Washington, and C.C. Black Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma Pancreas 38 1 2009 e1
59. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2 2009 215 233
60. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 1 2005 15 20
61. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 4 2006 259 269
62. P.A. Gregory, A.G. Bert, E.L. Paterson, S.C. Barry, A. Tsykin, and G. Farshid The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol 10 5 2008 593 601
63. S. Brabletz, K. Bajdak, S. Meidhof, U. Burk, G. Niedermann, and E. Firat The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells EMBO J 30 4 2011 770 782
64. J. Yu, K. Ohuchida, K. Mizumoto, N. Sato, T. Kayashima, and H. Fujita MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation Mol Cancer 9 2010 169
65. M. Preis, T.B. Gardner, S.R. Gordon, J.M. Pipas, T.A. Mackenzie, and E.E. Klein MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma Clin cancer Res Official J Am Assoc Cancer Res 17 17 2011 5812 5821
66. C. Li, C.J. Lee, and D.M. Simeone Identification of human pancreatic cancer stem cells Methods Mol Biol 568 2009 161 173
67. S.A. Mani, W. Guo, M.-J. Liao, E.N. Eaton, A. Ayyanan, and A.Y. Zhou The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 4 2008 704 715
68. A. Singh, and J. Settleman EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 34 2010 4741 4751
69. C. Li, D.G. Heidt, P. Dalerba, C.F. Burant, L. Zhang, and V. Adsay Identification of pancreatic cancer stem cells Cancer Res 67 3 2007 1030 1037
70. Y.H. Lu, H. Zhu, Z.W. Wang, X.J. Fan, S.J. Zhu, and X.H. Li Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell Zhonghua Yi Xue Za Zhi 91 44 2011 3107 3110
71. D. Mizrak, M. Brittan, and M. Alison CD133: molecule of the moment J Pathol 214 1 2008 3 9
72. P.C. Hermann, S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, and M. Guba Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 3 2007 313 323
73. H. Immervoll, D. Hoem, P.O. Sakariassen, O.J. Steffensen, and A. Molven Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas BMC Cancer 8 2008 48
74. B. Giebel, D. Corbeil, J. Beckmann, J. Hohn, D. Freund, and K. Giesen Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells Blood 104 8 2004 2332 2338
75. Q. Ding, M. Yoshimitsu, T. Kuwahata, K. Maeda, T. Hayashi, and T. Obara Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic cancer Hum Cell 25 1 2012 1 8
76. S. Jones, X. Zhang, D.W. Parsons, J.C. Lin, R.J. Leary, and P. Angenendt Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 5897 2008 1801 1806
77. S.K. Dissanayake, M. Wade, C.E. Johnson, M.P. O'Connell, P.D. Leotlela, and A.D. French The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition J Biol Chem 282 23 2007 17259 17271
78. K.J. Wu Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance Chang Gung Med J 34 3 2011 229 238
79. K.J. Wu, and M.H. Yang Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection Biosci Rep 31 6 2011 449 455
80. I. Ben-Porath, M.W. Thomson, V.J. Carey, R. Ge, G.W. Bell, and A. Regev An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors Nat Genet 40 5 2008 499 507
81. A. Kabashima, H. Higuchi, H. Takaishi, Y. Matsuzaki, S. Suzuki, and M. Izumiya Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion Int J Cancer 124 12 2009 2771 2779
82. H. Niess, P. Camaj, A. Renner, I. Ischenko, Y. Zhao, and S. Krebs Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis Target Oncol 2014 Jun 22 [Epub ahead of print]
83. A. Gschwind, O.M. Fischer, and A. Ullrich The discovery of receptor tyrosine kinases: targets for cancer therapy Nat Rev Cancer 4 5 2004 361 370
84. S.R. Boreddy, and S.K. Srivastava Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model Oncogene 32 34 2013 3980 3991
85. Y. Li, T.G. VandenBoom 2nd, D. Kong, Z. Wang, S. Ali, and P.A. Philip Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells Cancer Res 69 16 2009 6704 6712
86. N.A. Dallas, L. Xia, F. Fan, M.J. Gray, P. Gaur, and G. van Buren 2nd Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition Cancer Res 69 5 2009 1951 1957
87. M.A. Nieto, and A. Cano The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity Semin Cancer Biol 22 5-6 2012 361 368
88. J. Heuberger, and W. Birchmeier Interplay of cadherin-mediated cell adhesion and canonical wnt signaling Cold Spring Harb Perspect Biol 2 2 2010 a002915 10.1101/cshperspect.a002915
89. M. Kwon, S.J. Lee, Y. Wang, Y. Rybak, A. Luna, and S. Reddy Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis Int J Cancer 135 1 2014 48 60
90. M. Kwon Epithelial-to-mesenchymal transition and cancer stem cells: emerging targets for novel cancer therapy Cancer Gene Ther 21 5 2014 179 180
91. M. Kwon, S.J. Lee, S. Reddy, Y. Rybak, A. Adem, and S.K. Libutti Down-regulation of filamin A interacting protein 1-like is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers PLoS One 8 12 2013 e82620
92. A.N. Shah, J.M. Summy, J. Zhang, S.I. Park, N.U. Parikh, and G.E. Gallick Development and characterization of gemcitabine-resistant pancreatic tumor cells Ann Surg Oncol 14 12 2007 3629 3637
93. Z. Wang, Y. Li, D. Kong, S. Banerjee, A. Ahmad, and A.S. Azmi Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway Cancer Res 69 6 2009 2400 2407
94. R. Plentz, J.S. Park, A.D. Rhim, D. Abravanel, A.F. Hezel, and S.V. Sharma Inhibition of γ-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma Gastroenterology 136 5 2009 1741.e6-1749.e6. http://dx.doi.org/10.1053/j.gastro.2009.01.008
95. T. Arumugam, V. Ramachandran, K.F. Fournier, H. Wang, L. Marquis, and J.L. Abbruzzese Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer Cancer Res 69 14 2009 5820 5828
96. M. Lang Infinity Pharma halts pancreatic cancer trial 2012 Available from: http://www.bizjournals.com/boston/blog/mass-high-tech/2012/01/infinity-pharma-halts-pancreatic-cancer-trial.html
97. D. Catenacci, N. Bahary, S.R. Nattam, R. Marsh, J. Wallace, and L. Rajdev Final analysis of a phase IB/randomized phase II study of gemcitabine (G) plus placebo (P) or vismodegib (V), a hedgehog (Hh) pathway inhibitor, in patients (pts) with metastatic pancreatic cancer (PC): a University of Chicago Phase II Consortium Study J Clin Oncol 31 2013 [suppl; abstr 4012]
98. S. Sahebjam, P.L. Bedard, V. Castonguay, Z. Chen, M. Reedijk, and G. Liu A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503) Br J Cancer 109 4 2013 943 949